Purchase Order 75D30126P21063

The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $205,000 purchase order to Qiagen, LLC for their EZ! ADVANCED XL SYSTEM. Qiagen, a subsidiary of Qiagen N.V., will provide its sample preparation and nucleic acid extraction platform to support CDC programs through a one-month period of performance ending in late August 2023. The firm fixed price contract calls for Qiagen to deliver its proprietary system to help CDC process samples...

<p>The CDC Pittsburgh issued a purchase order to Qiagen, LLC on May 29, 2026, for laboratory equipment service, valued at $15,157.00, with an ultimate completion date of May 28, 2027. The order covers QIAGEN laboratory equipment service contract work under Executive Order 14398. Performance occurs in Atlanta, Georgia. The contract is firm fixed price with no small business set-aside.</p>

The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $134,109.65 purchase order to Qiagen, LLC for laboratory supplies. Qiagen, LLC is a division of Qiagen N.V., which will serve as the prime contractor. The contract has a firm fixed price and period of performance from July 25, 2023 through July 25, 2024. No additional details were provided on the requested products or services, however based on the funding agency, the laboratory...

The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $32,000 purchase order to Qiagen, LLC for a QIAGEN ROBOT. Qiagen, LLC is a division of Qiagen N.V., which will serve as the prime contractor to deliver the robotic system to the CDC location in Germantown, Maryland between September 12-29, 2023. The contract has a firm fixed price and will support the CDC's efforts to modernize its laboratory equipment and processes. No major...

Qiagen, LLC was awarded a purchase order for $66,592.30 by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to provide EZ1 &amp; 2 DNA Tissue Kits, Buffer AL, and Qiagen Proteinase K. No set-aside designation was applied to this contract. Performance will take place in Germantown, Maryland through August 31, 2023. Qiagen, a division of Qiagen N.V., will deliver the requested DNA extraction products to support the Centers for Disease Control and...

The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a firm fixed-price purchase order totaling $14,288 to Qiagen, LLC for laboratory services under the QIAGEN LAB SERVICES program. The contract, issued on April 1, 2025, with an ultimate completion date of March 31, 2026, represents a task order call against a larger vehicle supporting CDC's diagnostic and laboratory capabilities. Qiagen, a Germantown, Maryland-based manufacturer of molecular diagnostics and scientific...

The U.S. Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $25,310 firm fixed-price purchase order to Qiagen, LLC for IT services and annual maintenance. The contract, which was executed on May 18, 2015 with an ultimate completion date of September 28, 2020, was not issued under a set-aside designation, reflecting Qiagen's ability to compete in the open federal marketplace. Performance is located in Atlanta, Georgia. Qiagen, LLC, a subsidiary of Netherlands-based Qiagen N.V.,...

This federal contract award with ID 75D30124P19812 was issued by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Qiagen, LLC, a division of the international diagnostics company Qiagen N.V. The $219,630.87 firm fixed-price purchase order is for Qiagen's EZ2 CONNECT MDX IVD Extraction System, a sample preparation device used in molecular diagnostics. The contract has a period of performance through November 27, 2024. Qiagen has provided a range of products and services to...

The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $5,570 firm fixed-price purchase order to Qiagen, LLC for equipment maintenance services on April 21, 2025, with an ultimate completion date of April 18, 2026. This contract, which carries no set-aside designation, represents a task order issued under one of Qiagen's existing indefinite delivery vehicles with CDC. The work will be performed in Germantown, Maryland, where Qiagen maintains its headquarters as a foreign-owned...

The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a firm fixed price purchase order valued at approximately $8,721 to Qiagen, LLC for the delivery of TISSUELYSER LT laboratory equipment. As a division of Qiagen N.V., Qiagen will perform as the prime contractor under the contract to provide the requested products and services. The place of performance will be Qiagen's Germantown, Maryland facility. The period of performance spans from...